Skip to content

NSRX NASUS PHARMA LTD

Follow

ORD SHS (common), issuer CIK 2029039

Filings received so far for Q3 2026: 9 13F filers report a position in NSRX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Balyasny Asset Management L.P.in group Balyasny Asset Management898,473$3.32M0.01%013F-HRTimelineGroup
Cable Car Capital, LP616,081$2.27M0.66%013F-HRTimeline
Velan Capital Investment Management LP359,390$1.33M1.27%013F-HRTimeline
Hudson Bay Capital Management LPin group Hudson Bay Capital Management…134,771$497K<0.01%013F-HRTimelineGroup
Bleichroeder LPin group Bleichroeder LP89,848$332K0.03%013F-HRTimelineGroup
RENAISSANCE TECHNOLOGIES LLCin group RENAISSANCE TECHNOLOGIES LLC14,600$53.9K<0.01%+2,40013F-HRTimelineGroup
Pinnacle Financial Group, Inc.9,712$35.8K<0.01%13F-HRTimeline
MORGAN STANLEYin group MORGAN STANLEY1,000$3.69K<0.01%013F-HRTimelineGroup
Caitong International Asset Management …4$15<0.01%013F-HRTimeline

Events

  • Balyasny Asset Management L.P. and 4 other reporting persons reported 1,170,209 NSRX shares, 9.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-16. 0001172661-26-005053

    Accepted , ingested